Infection of epithelial-derived cells by adenovirus vectors
Ad vectors have varied effects on infected cells mediated by viral attachment, internalization and translocation, and/or gene expression. 1 Viral vector infection induces a number of physiologically relevant proteins through a yet undisclosed number of pathways in the cell signaling cascade. [1] [2] [3] [4] [5] [6] [7] [8] Importantly, endogenous gene induction by viral vectors used in gene therapy may negatively impact on the intended therapeutic goals of the application. In this context, induction of cyclo-oxygenase (COX)-2 protein and the related increases in prostaglandin E-2 (PGE-2) associated with Ad vector use in cancer gene therapy may have significant therapeutic implications. The current experiments describe the upregulation of COX-2 protein and parallel induction of PGE-2 following Ad vector (⌬E1, ⌬E3, Ad5) infection. Experiments define the pivotal role of ERK/MAP kinase activation in this phenomenon and further show that Ad vector gene expression is responsible for this activity. Because Ad vectors have been shown to induce NF-kappa B (NFB) in other cell lines and NFB has been described as a transcription factor for COX-2, experiments also examine the role of Ad induced NFB induction in COX-2 upregulation. [9] [10] [11] [12] Initial experiments define the induction of PGE-2 by AdGFP (MOI 25) and the connection between COX-2 enzyme activity and PGE-2 production in established non-small cell lung cancer (NSCLC) cell lines NCI-820 and NCI-460, both of which constitutively produce moderate amounts of PGE-2. Data show a two-fold increase in PGE-2 produced by NCI-820 and a four-fold increase in production by NCI-460. The selective COX-2 inhibitor NS398 reduced production of PGE-2 to baseline levels and prevented increases seen with Ad infection in both cell lines (Figure 1 ).
To further evaluate this effect, NCI-820 was infected with AdGFP at various MOI (0, 25, 50, 100) and production of PGE-2 was evaluated at time-points 24 and 48 h after infection. The data show a dose-and time-dependent increase in PGE-2 production, with marginal increases in PGE-2 at 24 h only at MOI 100 (not shown) and more dramatic increases, in a dose-dependent fashion, at 48 h. Increases at 48 h were similar to those seen with addition of recombinant IL1␤ at 24 h (P Ͻ 0.01) ( Figure 2 ). These data indicate that increases in PGE-2 are delayed compared with those seen following the addition of IL1␤. Induction of PGE-2 by UV-inactivated AdGFP was also evaluated to examine the relative importance of Ad attachment and internalization versus gene expression in this phenomenon. UV inactivation allows viral entry into the cell, but makes the virus incapable of gene expression. 13 Notably, UV-inactivated AdGFP with equivalent particle numbers to intact virus did not induce similar increases in PGE-2 (P Ͻ 0.1 compared with controls) indicating that PGE-2 induction is related to vector gene expression following internalization and translocation to the nucleus (Figure 2 ). In groups that paralleled each of those described above, selective blockade of ERK/MAP kinase with the cell permeable inhibitor PD98059 reduced constitutive production of PGE-2 and abrogated induction following Ad infection. Data show a six-fold decrease in baseline levels of PGE-2 in uninfected cells and a three-to four-fold decrease of PGE-2 production in Ad-infected cells + PD98059. PD98059 also abrogated the increases in PGE-2 seen with IL1␤ ( Figure  2 ). The data further implicate ERK1/2 as a dominant signal in both constitutive COX-2 expression and in COX-2 induction by Ad vectors. Additional experiments evaluated PGE-2 induction by an Ad5null vector carrying no transgene and AdPSA carrying an alternate transgene. Both vectors induced significant increases in PGE-2, indicating this effect is transgene-independent (not shown).
Figure 2 PGE-2 production after AdGFP infection
In all experiments, GFP expression was seen in 100% of cells at MOI 25 with more intense fluorescence at MOI 50 and 100 and cells remained adherent and appeared healthy in all experimental groups.
Consistent with increases seen in PGE-2, COX-2 protein was visibly increased at 48 h after infection. Time course showed no discernable increases in COX-2 protein at 0-12 h (not shown). In the same samples, ERK activation was evaluated using an antibody specific for the phoshphorylated epitopes of ERK-1 and ERK-2 showing that increases in COX-2 protein expression were paralleled by increases in ERK phosphorylation. Also consistent with experiments evaluating induction of PGE-2, data show UV-inactivated Ad vectors do not induce COX-2 protein, nor do they lead to ERK phosphorylation ( Figure 3 ).
Because NFB has been shown to induce COX-2 protein transcription and Ad vectors have been previously shown to induce NFB, experiments were designed to evaluate a role for NFB in this phenomenon.
9-12 PGE-2 production was assessed in the presence of SN50, and inhibitor of NFB translocation. 12 Data show no effect of SN50 on PGE-2 production/induction by Ad infection (Figure 4 ). In addition, NFB activity following Ad infection was evaluated using a NFB reporter plasmid, bearing a minimal promoter with a NFB-enhancer binding site, transiently transfected into NCI-820 cells. Data show an increase in luciferase activity following AdGFP infection, indicating NFB translocation to the nucleus. SN50 evaluated in transfected cells indicated this permeable inhibitor is active in this cell line, thus supporting evidence that NFB is not the primary nuclear factor responsible for COX induction by Ad vector infection ( Figure  5 ). Collectively the data indicate gene expression by ⌬E1, ⌬E3 Ad5 vectors induce ERK/MAP kinase activity that leads to increases in COX-2 protein and subsequent increases in PGE-2 production. Further, although Ad infection was shown to induce NFB, the blockade of NFB nuclear localization did not prevent increases in PGE-2 suggesting mediation by alternative nuclear signals/binding proteins.
The signaling cascade related to gene expression following Ad vector infection is increasingly more relevant MOI (0, 50, 100) with the variety of applications that are feasible with gene therapy. Ad vectors have been noted to have a variety of effects on cellular activity and function of epithelial-derived cells. These effects may be related to Ad vector attachment and/or internalization or viral gene expression. Notable observations include induction of IL8 via raf MAP kinase pathway in HeLa cells 4 and in A549 cells, 14 induction of PI3 kinase related to integrin signaling in SW480 colon carcinoma cells 5 and G2-M cell arrest in immortalized human bronchial epithelial cells via increases in cyclinD related to adenovirus expression of the E4 coding region. 6 Other studies also showing specific effects of E4 expression include induction of a variety of cellular cDNAs in HUVEC cells (signaling molecules, calcium-regulated/cytoskeletal proteins, growth factors, glyceraldehyde-6-phosphate dehydrogenase, an expressed sequence tag, and a novel cDNA showing homology to a LIM domain sequence) 7 and induction of cell survival signals via BCL-2 induction in primary human endothelial cells. 8 The induction of ERK-MAP kinase/COX-2/PGE-2 described in the current report contributes to the list of biologically and therapeutically relevant effects of Ad vector infection. Data also show NFB nuclear binding is increased by ⌬E1, ⌬E3 Ad5 vector infection although it does not play a major role in COX-2 induction, thus more extensive investigations of NFB activation are beyond the scope of this report. Although the specific gene sequences have not been identified by the current experiments, data indicate this is transgene-independent. From the known literature, the E4 region of adenovirus could be implicated as a likely candidate. The significance of COX-2 expression by tumor cells lies in its regulation of downstream cellular events and also in its association with aberrant signaling events that regulate its expression, both of which drive tumorigenesis and survival in malignant cells. [15] [16] [17] In malignant cells, COX-2 overexpression has been shown to enhance cellular invasion, induce angiogenesis, regulate antiapoptotic cellular defenses and augment immunologic resistance.
15-21 COX-2 is the enzyme responsible for PGE-2 induction that has been shown to suppress T cellmediated immunity in a dose-dependent fashion. In this way, PGE-2 production by NSCLC has been defined as one mechanism whereby tumor cells escape immune destruction. [22] [23] [24] [25] [26] COX-2 overexpression is also seen in association with oncogenic ras expression and aberrantly expressed signaling cascades, making this protein a marker for the malignant phenotype. [15] [16] [17] [18] [19] [20] [21] In this context, the current paper describes biologically and therapeutically relevant changes seen in NSCLC tumor cells following ⌬E1, ⌬E3, Ad5 vector infection.
In the context of the current observations, ⌬E1, ⌬E3 Ad5 vectors may impact cancer gene therapy through activation of ERK/MAP kinase and upregulation of COX-2-enhanced production of PGE-2. This axis may afford survival advantages to tumor cells through antiapoptotic effects of COX-2-related pathways and potentiating a mitogenic, angiogenic and invasive phenotype. [15] [16] [17] [18] [19] [20] Additionally, the immunosuppressive effects of PGE-2 induced following Ad vector infection may be specifically counterproductive to gene-based immunotherapy for cancer. 15, 16, [22] [23] [24] [25] [26] Thus awareness of Ad vector effects on infected tumor cells is relevant and may impact on decisions regarding targets for cancer gene therapy, such as immune modulating strategies, and/or choice of vectors used (⌬E1, ⌬E3 versus ⌬E1, ⌬E4 or gutless vectors).
